Clinical Trial Update: A Safety Study of Tocilizumab to Improve Transplant Rates in Highly Sensitized Patients Awaiting Kidney Transplantation [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update reporting safety data for tocilizumab aimed at increasing transplant rates in highly sensitized patients with end-stage renal disease; Pha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Tocilizumab (tocilizumab)

Snippet

Sponsor: Cedars-Sinai Medical Center | Conditions: End Stage Renal Disease (ESRD) | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2015-08-05